Quest Diagnostics (DGX) Director Luis Diaz Receives 1,142 RSUs

What Happened

• Luis Diaz, a director of Quest Diagnostics (DGX), was granted 1,142 restricted stock units (RSUs) on 2026-05-20. The transaction is reported as an award/acquisition (code A) at $0.00 per share (award/compensation), so no cash was paid by the insider.

Key Details

• Transaction date: 2026-05-20; Form 4 filed: 2026-05-21 (timely filing).
• Transaction type/code: Award/Grant (A); 1,142 RSUs acquired at $0.00 per share.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: F1 — the reported units represent an award of restricted stock units (RSUs).
• No sale or cash purchase reported; this is a compensation grant rather than an open-market trade.

Context

• RSUs are a form of equity compensation that typically convert to shares upon vesting and may be subject to vesting schedules and tax withholding; they do not represent an immediate open-market purchase or sale.
• Awards to directors are common and reflect compensation practices rather than direct buying/selling sentiment; retail investors should view this as routine insider compensation unless accompanied by other trading activity.